Kera Capital Partners’s Pfizer PFE Stock Holding History

Kera Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$1.2K	–	582
2025 Q3	$1.2K	Hold	10,000	–	–	﹤0.01%	423
2025 Q2	$800	Hold	10,000	–	–	﹤0.01%	351
2025 Q1	$2.2K	Buy	+10,000	New	+$262K	﹤0.01%	187

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kera Capital Partners's PFE Position: Q2 2026 in Review

Kera Capital Partners increased its Pfizer (PFE) stake by 80% in Q2 2026, buying an estimated $249K and bringing the position to 21,323 shares worth $513K. The position accounts for 0.05% of the portfolio, ranked #315.

Kera Capital Partners first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kera Capital Partners held 21,323 shares of Pfizer worth $513K as of Q2 2026.
Kera Capital Partners bought 9,500 Pfizer shares in Q2 2026, an estimated $249K.
Pfizer made up 0.05% of Kera Capital Partners's portfolio in Q2 2026, its #315 holding.
Kera Capital Partners first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.